RANJITKAR MANANDHAR, Nora; KAYASTHA, Gyan Krishna; ACHARYA, Paras Kumar. Dasatinib tyrosine kinase inhibitor as second and third line therapy in chronic myeloid leukemia: outcome of a Nepalese study. Journal of Patan Academy of Health Sciences, [S. l.], v. 5, n. 1, p. 47–56, 2018. Disponível em: https://jpahs.edu.np/index.php/jpahs/article/view/97. Acesso em: 25 oct. 2024.